DAZLUMA Trademark

Trademark Overview

On Friday, October 2, 2020, a trademark application was filed for DAZLUMA with the United States Patent and Trademark Office. The USPTO has given the DAZLUMA trademark a serial number of 90232661. The federal status of this trademark filing is REGISTERED as of Tuesday, February 13, 2024. This trademark is owned by Biohaven Therapeutics Ltd.. The DAZLUMA trademark is filed in the Pharmaceutical Products category with the following description:

Medicated and pharmaceutical preparations, both prescription and over-the-counter, for use in connection with humans, namely, for the treatment of neuroinflammatory and neurodegenerative diseases and disorders, and for neuroprotection
dazluma

General Information

Serial Number90232661
Word MarkDAZLUMA
Filing DateFriday, October 2, 2020
Status700 - REGISTERED
Status DateTuesday, February 13, 2024
Registration Number7305018
Registration DateTuesday, February 13, 2024
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 6, 2021

Trademark Statements

Certificate of Correction for RegistrationIn the statement, line 9, " FIRST USE 11-15-2023" should be deleted, and "FIRST USE 11-16-2023" should be inserted.
Goods and ServicesMedicated and pharmaceutical preparations, both prescription and over-the-counter, for use in connection with humans, namely, for the treatment of neuroinflammatory and neurodegenerative diseases and disorders, and for neuroprotection
Certificate of Correction for RegistrationIn the statement, line 9, "FIRST USE 11-15-2023" should be deleted, and "FIRST USE 11-16-2023" should be inserted.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, November 17, 2020
Primary Code005
First Use Anywhere DateThursday, November 16, 2023
First Use In Commerce DateThursday, November 16, 2023

Trademark Owner History

Party NameBiohaven Therapeutics Ltd.
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressRoad Town, Tortola VG1110
VG
Party NameBiohaven Therapeutics Ltd.
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressRoad Town, Tortola VG1110
VG
Party NameBiohaven Therapeutics Ltd.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressNew Haven, CT 06510

Trademark Events

Event DateEvent Description
Tuesday, November 17, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, October 6, 2020NEW APPLICATION ENTERED
Saturday, February 27, 2021ASSIGNED TO EXAMINER
Saturday, February 27, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, March 17, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 6, 2021PUBLISHED FOR OPPOSITION
Tuesday, April 6, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 1, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, November 29, 2021SOU TEAS EXTENSION RECEIVED
Monday, November 29, 2021SOU EXTENSION 1 FILED
Monday, November 29, 2021SOU EXTENSION 1 GRANTED
Wednesday, December 1, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, May 20, 2022SOU TEAS EXTENSION RECEIVED
Friday, May 20, 2022SOU EXTENSION 2 FILED
Friday, May 20, 2022SOU EXTENSION 2 GRANTED
Tuesday, May 24, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, November 22, 2022SOU TEAS EXTENSION RECEIVED
Tuesday, November 22, 2022SOU EXTENSION 3 FILED
Tuesday, November 22, 2022SOU EXTENSION 3 GRANTED
Thursday, November 24, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, April 5, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, April 5, 2023SOU EXTENSION 4 FILED
Wednesday, April 5, 2023SOU EXTENSION 4 GRANTED
Friday, April 7, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, April 17, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, April 17, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, April 17, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, October 19, 2023SOU TEAS EXTENSION RECEIVED
Thursday, October 19, 2023SOU EXTENSION 5 FILED
Friday, October 27, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, October 27, 2023SOU EXTENSION 5 GRANTED
Saturday, October 28, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, December 13, 2023TEAS STATEMENT OF USE RECEIVED
Wednesday, December 13, 2023USE AMENDMENT FILED
Friday, December 15, 2023STATEMENT OF USE PROCESSING COMPLETE
Saturday, January 6, 2024ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, January 9, 2024NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, February 13, 2024REGISTERED-PRINCIPAL REGISTER
Tuesday, February 13, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
Thursday, February 22, 2024TEAS SECTION 7 REQUEST RECEIVED
Thursday, September 5, 2024CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Monday, September 16, 2024CORRECTION UNDER SECTION 7 - PROCESSED
Thursday, May 15, 2025CORRECTION UNDER SECTION 7 - PROCESSED
Tuesday, July 15, 2025NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED
Thursday, September 19, 2024ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Tuesday, April 29, 2025NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED
Friday, May 16, 2025ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED

Related Keywords

dazluma neuroinflammatory treatment namely neurodegenerative diseases neuroprotection disorders humans connection preparations